GTC Biotherapeutics (fka GTCB)

[croumagnon]

>I have a feeling that the so-called deal talking now is very likely a buyout.<
"Why do you think that?"

I tend to agree with him that a takeover currently is more likely than a partnership, and that perhaps that is the hangup because Cox and company are resisting...

It would make a lot more sense for a big company to pay somewhere around $100 Million for the whole Bonanaza instead of committing $20-$30 Million just to secure themselves ATryn US...